Lovenox (Enoxaparin)

Brand Options

arrow pointer

Brand Name : Lovenox

Marketing Authorization Holder : SANOFI

Prescription Required

 
 
No Generic Medicine available for this medicine.

Product Details

Lovenox

Lovenox is called Clexane in Europe.

Information about Lovenox (Enoxaparin)

Lovenox is a low molecular weight heparin (LMWH) used as an anticoagulant to prevent and treat certain blood clots. It helps lower the risk of complications associated with thromboembolic disorders.

Product Highlights

  • Prevention of deep vein thrombosis (DVT) in patients undergoing surgery or those with limited mobility.
  • Care for DVT and pulmonary embolism (PE).
  • Prevention of complications in individuals with acute coronary syndrome (ACS).

Key Ingredient

  • Enoxaparin Sodium

Key Benefits

  • Lowers the risk of thromboembolic events, including DVT and PE.
  • Easier to administer than unfractionated heparin, often requiring less frequent dosing.
  • Has a predictable pharmacokinetic profile, allowing for fixed dosing without routine monitoring.

Direction of Use

  • Administer Lovenox as directed by your healthcare provider, typically by subcutaneous injection.
  • Inject into the fatty tissue of the abdomen or thigh, as instructed.
  • Rotate injection sites to minimize irritation.
  • Refrain from rubbing the injection site after administration.

Safety Concerns

  • Common side effects may include bleeding, bruising at the injection site, and allergic reactions.
  • Monitor for signs of unusual bleeding, such as blood in urine or stool.
  • Regular blood tests may be required to monitor coagulation levels in some patients.

Avoid Lovenox (Enoxaparin) If

  • You are allergic to enoxaparin or any other ingredients in the formulation.
  • You have active bleeding or severe bleeding disorders.
  • You have a previous history of heparin-induced thrombocytopenia (HIT).
  • You are undergoing certain surgical procedures without adequate medical supervision.
  • You are pregnant or breastfeeding without consulting a healthcare provider first.


Image Image Image Image